Apellis Pharmaceuticals, Inc. (APLS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 03:44PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 5.79B |
| Enterprise Value | 5.55B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 14.36 |
| Price/Book (mrq) | 29.74 |
| Enterprise Value/Revenue | 13.98 |
| Enterprise Value/EBITDA | -11.20 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.89 |
| 52-Week Change 3 | -41.73% |
| S&P500 52-Week Change 3 | 21.61% |
| 52 Week High 3 | 94.75 |
| 52 Week Low 3 | 19.83 |
| 50-Day Moving Average 3 | 60.67 |
| 200-Day Moving Average 3 | 52.80 |
Share Statistics
| Avg Vol (3 month) 3 | 1.36M |
| Avg Vol (10 day) 3 | 1.23M |
| Shares Outstanding 5 | 120.58M |
| Implied Shares Outstanding 6 | 120.58M |
| Float 8 | 81.04M |
| % Held by Insiders 1 | 13.23% |
| % Held by Institutions 1 | 95.99% |
| Shares Short (Mar 28, 2024) 4 | 10.44M |
| Short Ratio (Mar 28, 2024) 4 | 7.76 |
| Short % of Float (Mar 28, 2024) 4 | 10.05% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 8.66% |
| Shares Short (prior month Feb 29, 2024) 4 | 10.06M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -133.29% |
| Operating Margin (ttm) | -57.74% |
Management Effectiveness
| Return on Assets (ttm) | -41.73% |
| Return on Equity (ttm) | -290.14% |
Income Statement
| Revenue (ttm) | 396.59M |
| Revenue Per Share (ttm) | 3.34 |
| Quarterly Revenue Growth (yoy) | 545.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | -515.34M |
| Net Income Avi to Common (ttm) | -528.63M |
| Diluted EPS (ttm) | -4.45 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 355.54M |
| Total Cash Per Share (mrq) | 2.95 |
| Total Debt (mrq) | 110.93M |
| Total Debt/Equity (mrq) | 57.03% |
| Current Ratio (mrq) | 3.10 |
| Book Value Per Share (mrq) | 1.63 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -594.73M |
| Levered Free Cash Flow (ttm) | -404.84M |
© 2024 Yahoo. All rights reserved.